 AMAG Pharmaceuticals NASDAQ:AMAG was upgraded by equities research analysts at BidaskClub from a sell rating to a hold rating in a report released on Thursday, BidAskClub reports. Several other equities research analysts also recently weighed in on AMAG. HC Wainwright increased their price objective on AMAG Pharmaceuticals from 9.00 to 10.00 and gave the company ... 